Company Profile
Acadia Healthcare Stock Price, News & Analysis
- Ticker:
- ACHC
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Acadia Healthcare is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
24.54 USD (-2.66%)
Close
Last updated: June 23, 2026 at 00:00
2.26B USD
Market cap
Why the stock is moving
ACHC is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Acadia Healthcare is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Acadia Healthcare follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Acadia Healthcare sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance
Source: Acadia Healthcare
- 02
Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference
Source: Acadia Healthcare
- 03
Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer
Source: Acadia Healthcare
- 04
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release
Source: Acadia Healthcare
- 05
Acadia Healthcare to Participate in March Investor Conferences
Source: Acadia Healthcare
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Acadia Healthcare (ACHC)?
Acadia Healthcare (ACHC) most recently closed at 24.54 USD, a -2.66% move versus the previous session.
What is the market cap of Acadia Healthcare (ACHC)?
Acadia Healthcare currently has a market capitalization of 2.26B USD on BioPharmSignal.
What does Acadia Healthcare do?
Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ACHC stock listed?
Acadia Healthcare (ACHC) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Acadia Healthcare is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Acadia?
Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Acadia Healthcare targeting with Acadia?
Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Healthcare?
Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.